Patricia L. Kavanagh, MD
Associate Professor
Boston University Chobanian & Avedisian School of Medicine
Pediatrics
General Pediatrics

MD, Boston University
BA, Boston University
BS, Boston University



Dr. Kavanagh has a national reputation in using systems approaches to improve the care of children and adults with sickle cell disease in the emergency department setting. As an attending physician in the pediatric ED, she and colleagues defined and refined treatment standards for children with sickle cell disease. She has similarly worked to improve care for adults with sickle cell disease in the ED through guideline-based care pathways and the use of individualized pain protocols. She gives lectures at regional and national meetings throughout the United States to teach providers about interventions that improve ED care for sickle cell-related pain and outcomes for individuals living with sickle cell disease, and will serve as faculty for the 2023 Sickle Cell Disease Centers Workshop, sponsored by the American Society of Hematology. Her current grant activities include studying the impact of screening and referring families with unmet basic needs on health on outcomes for children with sickle cell disease, and serving as a subject matter expert in a multisite randomized trial comparing individualized pain plans with weight-based protocols. Nationally she co-founded and serves as Chair of the Emergency Department Sickle Cell Care Coalition. She completed her pediatrics residency at Boston Children’s Hospital and Boston Medical Center, and a fellowship in General Academic Pediatrics at Chobanian and Avedisian School of Medicine/Boston Medical Center.

Member
Boston University
Center of Excellence in Sickle Cell Disease





NHLBI Diversity Supplement: Understanding and Addressing the Social Determinants of Health for Families
09/28/2020 - 02/29/2024 (PI)
National Heart, Lung, and Blood Institute/NIH/DHHS

Understanding and Addressing the Social Determinants of Health for Families of Children with…
05/16/2019 - 02/29/2024 (PI)
National Heart, Lung, and Blood Institute/NIH/DHHS
1R01HL141774-01A1

1/2 A comparison of individualized vs. weight based protocols to treat vaso-occlusive episodes in Sickle Cell Disease (COMPARE VOE)
09/07/2018 - 08/31/2023 (PI)
Duke University National Heart, Lung
5UH3HL137856-04

Understanding and Addressing the Social Determinants of Health for Families of Children with Sickle Cell Anemia within Pediatric Hematology
06/01/2022 - 02/28/2023 (PI)
University of Massachusetts Medical School / UMASS National Heart, Lung

Sickle Cell Treatment Demonstration Program
09/01/2017 - 08/31/2021 (PI)
Johns Hopkins University Maternal and Child H

Eleminating suffering in the emergency room treatment of sickle cell vaso-occlusive crisis
09/01/2016 - 08/31/2018 (PI)
Georgia Medical Care Foundation Centers for Medicare

Management of Sickle Cell Disease-Related Pain in Children
08/10/2011 - 07/31/2017 (PI)
NIH-NHLBI
5K23HL105667-05

Patient Navigation in Sickle Cell Disease
06/01/2013 - 05/31/2014 (PI)
University of New Hampshire HRSA

Improving Quality of Care for Children with Sickle Cell Disease
09/01/2009 - 02/25/2011 (PI)
DM Noonan Mem Fund


Title


Yr Title Project-Sub Proj Pubs
2022 Understanding and Addressing the Social Determinants of Health for Families of Children with Sickle Cell Anemia within Pediatric Hematology 5R01HL141774-04
2022 Understanding and Addressing the Social Determinants of Health for Families of Children with Sickle Cell Anemia within Pediatric Hematology 3R01HL141774-04S1
2021 Understanding and Addressing the Social Determinants of Health for Families of Children with Sickle Cell Anemia within Pediatric Hematology 5R01HL141774-03
2020 Understanding and Addressing the Social Determinants of Health for Families of Children with Sickle Cell Anemia within Pediatric Hematology Diversity Supplement 3R01HL141774-02S1
2020 Understanding and Addressing the Social Determinants of Health for Families of Children with Sickle Cell Anemia within Pediatric Hematology 5R01HL141774-02
2019 Understanding and Addressing the Social Determinants of Health for Families of Children with Sickle Cell Anemia within Pediatric Hematology 1R01HL141774-01A1
2015 Management of Sickle Cell Disease-Related Pain in Children 5K23HL105667-05
2014 Management of Sickle Cell Disease-Related Pain in Children 5K23HL105667-04
2013 Management of Sickle Cell Disease-Related Pain in Children 5K23HL105667-03
2012 Management of Sickle Cell Disease-Related Pain in Children 5K23HL105667-02
Showing 10 of 11 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Tanabe P, Ibemere S, Pierce AE, Freiermuth CE, Bosworth HB, Yang H, Osunkwo I, Paxton JH, Strouse JJ, Miller J, Paice JA, Veeramreddy P, Kavanagh PL, Wilkerson RG, Hughes R, Barnhart HX. A Comparison of the effect of patient-specific vs. weight-based protocols to treat vaso-occlusive episodes (VOE) in the emergency department. Acad Emerg Med. 2023 Sep 20. PMID: 37731093
     
  2. Long KA, Blakey AO, Amaro CM, Eilenberg JS, Brochier A, Garg A, Drainoni ML, Pashankar F, Esrick EB, Kavanagh PL. Bidirectional processes linking social determinants of health and pediatric sickle cell anemia management: A qualitative study. Pediatr Blood Cancer. 2023 Oct; 70(10):e30539.View Related Profiles. PMID: 37470711; PMCID: PMC10619973; DOI: 10.1002/pbc.30539;
     
  3. Blakey AO, Lavarin C, Brochier A, Amaro CM, Eilenberg JS, Kavanagh PL, Garg A, Drainoni ML, Long KA. Effects of Experienced Discrimination in Pediatric Sickle Cell Disease: Caregiver and Provider Perspectives. J Racial Ethn Health Disparities. 2022 Dec 19.View Related Profiles. PMID: 36536165
     
  4. Kavanagh PL, Fasipe T, Wun T. A Review of Sickle Cell Disease-Reply. JAMA. 2022 Nov 15; 328(19):1979-1980. PMID: 36378210; DOI: 10.1001/jama.2022.16735;
     
  5. Kavanagh PL, Fasipe TA, Wun T. Sickle Cell Disease: A Review. JAMA. 2022 07 05; 328(1):57-68. PMID: 35788790
     
  6. Kavanagh PL, Frater F, Navarro T, LaVita P, Parrish R, Iorio A. Optimizing a literature surveillance strategy to retrieve sound overall prognosis and risk assessment model papers. J Am Med Inform Assoc. 2021 03 18; 28(4):766-771. PMID: 33484123; PMCID: PMC7973466; DOI: 10.1093/jamia/ocaa232;
     
  7. Loo S, Brochier A, Wexler MG, Long K, Kavanagh PL, Garg A, Drainoni ML. Addressing unmet basic needs for children with sickle cell disease in the United States: clinic and staff perspectives. BMC Health Serv Res. 2021 Jan 12; 21(1):55.View Related Profiles. PMID: 33435984; PMCID: PMC7802171; DOI: 10.1186/s12913-020-06055-y;
     
  8. Ibemere SO, Dubbs SB, Barnhart HX, Brown JL, Freiermuth CE, Kavanagh P, Paice JA, Strouse JJ, Wilkerson RG, Tanabe P. Trial design of comparing patient-specific versus weight-based protocols to treat vaso-occlusive episodes in sickle cell disease (COMPARE-VOE). Contemp Clin Trials. 2021 02; 101:106252. PMID: 33348066; PMCID: PMC7954959; DOI: 10.1016/j.cct.2020.106252;
     
  9. Kavanagh PL, Hirshon JM. EDSC3: Working to Improve Emergency Department Care of Individuals With Sickle Cell Disease. Ann Emerg Med. 2020 09; 76(3S):S80-S82. PMID: 32928468
     
  10. Brousseau DC, Muslu CS, Visotcky A, Fraser R, Kavanagh PL, Chelius TH, Schuh AM. Teaching Versus Nonteaching Hospitals: Where Children With Sickle Cell Disease Receive Their Emergency Department Care. J Pediatr Hematol Oncol. 2020 08; 42(6):412-413. PMID: 32404689
     
Showing 10 of 32 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 32 publications over 17 distinct years, with a maximum of 5 publications in 2020

YearPublications
19981
20001
20082
20092
20101
20113
20121
20132
20143
20151
20171
20181
20191
20205
20212
20223
20232

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

health services research
quality indicators
quality of care
sickle cell disease

I have mentored fellows, residents and students in research projects, with most concentrated on issues relevant to individuals living with sickle cell disease.

Available to Mentor as: (Review Mentor Role Definitions):
  • Career Mentor
  • Co-Mentor or Peer Mentor
  • Research / Scholarly Mentor
Contact for Mentoring:
  • Email (see 'Contact Info')

617.414.3573
Download vCard

Kavanagh's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
See all (173) concept(s)
_
Co-Authors
See all (6) people
_
Similar People
See all (60) people
_
Same Department
Search Department